RCI
AGTC

Ridgeback Capital Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Ridgeback Capital Investments’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-246,005
Closed -$5.02M – 2
2015
Q4 		$5.02M Buy
+246,005
New +$3.79M 21.59% 2
2015
Q1 		– Sell
-1,364,941
Closed -$28.7M – 1
2014
Q4 		$28.7M Buy
+1,364,941
New +$27.8M 100% 1

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ridgeback Capital Investments's AGTC Position: Q1 2016 in Review

Ridgeback Capital Investments sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2016, closing a stake of 246,005 shares — an estimated $5.02M sold.

Ridgeback Capital Investments first reported a position in AGTC in Q4 2014 and held it in 2 quarters. The position peaked at $28.7M in Q4 2014. 90 funds tracked by Wall St. Rank hold AGTC as of Q1 2016.

  • Ridgeback Capital Investments reported no remaining Applied Genetic Technologies Corporation position as of Q1 2016 after selling out during the quarter.
  • Ridgeback Capital Investments sold 246,005 Applied Genetic Technologies Corporation shares in Q1 2016, an estimated $5.02M.
  • Ridgeback Capital Investments first reported a position in Applied Genetic Technologies Corporation in Q4 2014 and held it in 2 quarters.
  • Ridgeback Capital Investments's Applied Genetic Technologies Corporation position peaked at $28.7M in Q4 2014.
  • 90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2016.

Based on Ridgeback Capital Investments's 13F filing for Q1 2016.